Marilyn Drake

Marilyn Drake is an accomplished professional with extensive experience in the diagnostics and molecular medicine sectors. Currently serving as Associate Director of National Accounts at Foundation Medicine since August 2025, Marilyn previously held the position of Molecular Enterprise Director at QuidelOrtho from August 2022 to August 2025. Marilyn's career includes significant roles at Accelerate Diagnostics, where responsibilities included driving national sales growth for the Pheno system and leading pre-launch commercialization strategies, as well as a notable tenure at Roche, where key achievements included managing national key accounts and fostering strategic relationships within the diagnostics industry. Marilyn earned multiple awards for outstanding performance and holds a degree from Indiana University Bloomington.